ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 53 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,919 | -12.8% | 6,396 | +0.2% | 0.00% | – |
| Q2 2023 | $2,201 | -55.9% | 6,381 | +0.4% | 0.00% | – |
| Q1 2023 | $4,991 | -21.3% | 6,358 | +0.2% | 0.00% | – |
| Q4 2022 | $6,345 | +26.9% | 6,345 | +0.4% | 0.00% | – |
| Q3 2022 | $5,000 | -28.6% | 6,318 | +0.3% | 0.00% | – |
| Q2 2022 | $7,000 | -93.7% | 6,301 | -92.1% | 0.00% | – |
| Q1 2022 | $111,000 | -68.0% | 80,189 | -47.4% | 0.00% | – |
| Q4 2021 | $347,000 | -73.8% | 152,560 | -52.0% | 0.00% | – |
| Q3 2021 | $1,324,000 | +182.3% | 317,601 | +221.9% | 0.00% | – |
| Q2 2021 | $469,000 | +801.9% | 98,676 | +1472.5% | 0.00% | – |
| Q1 2021 | $52,000 | +100.0% | 6,275 | +21.8% | 0.00% | – |
| Q4 2020 | $26,000 | – | 5,150 | +7703.0% | 0.00% | – |
| Q3 2020 | $0 | – | 66 | +8.2% | 0.00% | – |
| Q2 2020 | $0 | – | 61 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 61 | +74.3% | 0.00% | – |
| Q2 2019 | $0 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Richmond Brothers, Inc. | 494,042 | $148,212 | 0.28% |
| Quantum Private Wealth, LLC | 459,187 | $137,757 | 0.07% |
| Pasadena Private Wealth, LLC | 278,750 | $83,625 | 0.02% |
| Beta Wealth Group, Inc. | 32,000 | $9,600 | 0.01% |
| BRIGHTON JONES LLC | 338,491 | $101,548 | 0.01% |
| Balboa Wealth Partners | 47,500 | $14,250 | 0.01% |
| Waypoint Capital Advisors, LLC | 26,271 | $7,882 | 0.00% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 53,554 | $16,243 | 0.00% |
| Aureus Asset Management, LLC | 30,211 | $9,063 | 0.00% |
| AXXCESS WEALTH MANAGEMENT, LLC | 70,363 | $21,109 | 0.00% |